Skip to main content

Merit Medical Systems, Inc. (MMSI) Stock Analysis

Falling Knife setup

Buy WaitModerate Confidence

Healthcare · Medical Instruments & Supplies

Earnings in 0 days (2026-04-30). Expect elevated volatility around the report — consider waiting for post-earnings price action before new entries.

Wait — supporting gate not met yet. Price is at or below entry $67.44 but weak momentum; below 200-day MA (death cross) still blocks BUY_NOW.

Merit Medical Systems manufactures proprietary medical devices for interventional, diagnostic, and therapeutic procedures across cardiovascular and endoscopy segments, selling through direct sales and distributors globally. China is the company's largest international market by... Read more

$65.50+32.1% A.UpsideScore 5.9/10#3 of 25 Medical Instruments & Supplies
Entry $67.44(Support Atr Sticky)Stop $63.48Target $85.58(analyst − 13%)A.R:R 5.2:1
Analyst target$98.36+50.2%11 analysts
$85.58our TP
$65.50price
$98.36mean
$122

Wait — supporting gate not met yet. Price is at or below entry $67.44 but weak momentum; below 200-day MA (death cross) still blocks BUY_NOW. Chart setup: Death cross, below all MAs, RSI 37, MACD bearish. Earnings in 0 days. Wait until post-earnings. Score 5.9/10, moderate confidence.

Passes 4/7 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, semi cycle peak clear). Fails on weak momentum and death cross (50MA < 200MA) and earnings proximity 0d<=7d. Suitability: aggressive.

Thesis

Rewards
No bull case signals
Risks
No bear case signals

Key Metrics

P/E (TTM)30.4
P/E (Fwd)14.8
Mkt Cap$3.9B
EV/EBITDA13.3
Profit Mgn8.5%
ROE8.7%
Rev Growth10.9%
Beta0.65
DividendNone
Rating analysts18

Quality Signals

Piotroski F9/9

Options Flow

IV64%elevated

Concentration Risks(10-K Item 1A)

  • MEDIUMGeographicChina
    10-K Item 1A: 'China, our largest international market in terms of revenue. China has implemented the VBP policy, which has the specific aim of decreasing prices for medical devices.'

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

2 floor-breakers

Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static

Macd
0.0
Obv
1.0
Ma Position
1.0
Rsi
3.5
Volume
7.2
Volume distribution (falling OBV)Below 200-MA, MA slope -4.4%/30d — confirmed downtrend

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Growth Rank
4.5
Value Rank
5.2
Quality Rank
5.8
GatesMomentum 2.5<4.5Death cross (50MA < 200MA)EARNINGS PROXIMITY 0d<=7dA.R:R 5.2 ≥ 1.5Insider activity: OKNo SEC red flagsSEMI CYCLE PEAK CLEARFalling KnifeSuitability: Aggressive
RSI
37 · Neutral
20D MA 50D MA 200D MADEATH CROSSSupport $63.78Resistance $71.91

Price Targets

$63
$67
$86
A.Upside+30.7%
A.R:R5.2:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeCautious

Risk Alerts

! Earnings in 0 days - binary event risk
! Momentum score 2.5/10 — below 4.5 minimum
! Death cross — 50-day MA below 200-day MA

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-04-30 (0d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is MMSI stock a buy right now?

Wait — supporting gate not met yet. Price is at or below entry $67.44 but weak momentum; below 200-day MA (death cross) still blocks BUY_NOW. Chart setup: Death cross, below all MAs, RSI 37, MACD bearish. Earnings in 0 days. Wait until post-earnings. Target $85.58 (+30.7%), stop $63.48 (−3.2%), Setup A.R:R 7.1:1. Score 5.9/10, moderate confidence.

What is the MMSI stock price target?

Take-profit target: $85.58 (+32.1% upside). Target $85.58 (+30.7%), stop $63.48 (−3.2%), Setup A.R:R 7.1:1. Stop-loss: $63.48.

Is MMSI overvalued or undervalued?

Merit Medical Systems, Inc. trades at a P/E of 30.4 (forward 14.8). TrendMatrix value score: 6.7/10. Verdict: Buy (Wait for Entry).

What do analysts say about MMSI?

18 analysts cover MMSI with a consensus score of 4.2/5. Average price target: $98.

What does Merit Medical Systems, Inc. do?Merit Medical Systems manufactures proprietary medical devices for interventional, diagnostic, and therapeutic...

Merit Medical Systems manufactures proprietary medical devices for interventional, diagnostic, and therapeutic procedures across cardiovascular and endoscopy segments, selling through direct sales and distributors globally. China is the company's largest international market by revenue, but VBP policy-driven price cuts have negatively impacted pricing since 2022.

Related stocks: WST (West Pharmaceutical Services, I) · STVN (Stevanato Group S.p.A.) · RMD (ResMed Inc.) · ATRC (AtriCure, Inc.) · SOLV (Solventum Corporation)